3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Sponsor Class
OTHER
1
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Gastrointestinal
1
Conditions
Precursor Cell Lymphoblastic Leukemia-Lymphoma
21
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
16
Leukemia
7
Leukemia, Myeloid, Acute
6
Blast Crisis
6
Leukemia, Myeloid, Accelerated Phase
5
Carcinoma, Non-Small-Cell Lung
5
Leukemia, Myeloid, Chronic-Phase
4
Neoplasms
2
Myelodysplastic Syndromes
2
Leukemia, Myelomonocytic, Chronic
2
Breast Neoplasms
2
Thrombocytosis
1
Small Cell Lung Carcinoma
1
Prostatic Neoplasms
1
Primary Myelofibrosis
1
Piebaldism
1
Philadelphia Chromosome
1
Pancreatic Neoplasms
1
Neoplasm Metastasis
1
Myeloproliferative Disorders
1
Myelodysplastic-Myeloproliferative Diseases
1
Multiple Myeloma
1
Malignant Hepatobiliary Neoplasm
1
Lymphoma, Non-Hodgkin
1
Lung Neoplasms
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Hodgkin Disease
1
Hematologic Neoplasms
1
Interventions
Imatinib Mesylate
32
regorafenib
9
Sunitinib
9
Laparoscopy
5
Dasatinib
4
Blood Specimen Collection
4
pazopanib
3
nilotinib
3
Surveys and Questionnaires
3
Surgical Procedures, Operative
3
Paclitaxel
3
Observation
3
spartalizumab
2
ripretinib
2
envafolimab
2
binimetinib
2
apatinib
2
Temozolomide
2
Neoadjuvant Therapy
2
Ipilimumab
2
Gemcitabine
2
Docetaxel
2
Cisplatin
2
Carboplatin
2
Capecitabine
2
CTLA-4 Antigen
2
Biopsy, Fine-Needle
2
Biopsy
2
5-(2,4-dihydroxy-5-isopropylphenyl)-4-(4-morpholin-4-ylmethylphenyl)isoxazole-3-carboxylic acid ethylamide
2
4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Gastrointestinal Stromal Tumors
×
ponatinib
×
Clear all
NCT03171389
2017-05-31
POETIG
Universität Duisburg-Essen
Phase 2
Unknown
81 enrolled